GG. NG from YMB ? I agree ...Vascepa is safe and effective and if you believe it will it actually show a reduction in CV events ...all the reason to use it . I agree it's worth spending the $ I wrote about Dr Nissen and Dr Ballantyne presentations in the lipid / metabolic section of Heartwire ( found in bottom right of front page for those looking for them ). .... because these are thought leaders in the field and represent two different views which will effect scrips written . Dr Nissen is commenting on PPAR's ( Fibrates etc ) not on Vascepa per se but expains why he wants outcome data in general before prescribing in many instances . Dr Ballantyne however makes the case in a separate presentation that most of all Vascepa is safe ...so it should be prescribed because it is shown to lower risk markers ( high TG's etc ) IMHO these two different opinions are likely to influence scrip #'s One saying wait for Outcome data , the other saying it's safe and effective in reducing risk markers so be proactive AK
News 
Market Data 
Discover 
